Walleye Capital LLC Astria Therapeutics, Inc. Transaction History
Walleye Capital LLC
- $38.9 Billion
- Q4 2024
A detailed history of Walleye Capital LLC transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 145,402 shares of ATXS stock, worth $936,388. This represents 0.0% of its overall portfolio holdings.
Number of Shares
145,402
Previous 174,581
16.71%
Holding current value
$936,388
Previous $1.92 Million
33.4%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ATXS
# of Institutions
115Shares Held
50.3MCall Options Held
75KPut Options Held
6.2K-
Perceptive Advisors LLC New York, NY6.49MShares$41.8 Million1.91% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.11MShares$32.9 Million0.73% of portfolio
-
Vestal Point Capital, LP New York, NY4.18MShares$26.9 Million2.22% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.55MShares$22.9 Million6.29% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$22.7 Million0.0% of portfolio
About Astria Therapeutics, Inc.
- Ticker ATXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,178,000
- Market Cap $97.7M
- Description
- Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...